Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial2018-01-17T17:03:58-05:00
MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system2018-01-17T17:03:58-05:00
Effects of Seasons on Magnetic Resonance Imaging–Measured Disease Activity in Patients with Multiple Sclerosis Effects of Seasons on Magnetic Resonance Imaging–Measured Disease Activity in Patients with Multiple Sclerosis2018-01-17T17:03:46-05:00
Therapeutic Considerations for Disease Progression in Multiple Sclerosis Therapeutic Considerations for Disease Progression in Multiple Sclerosis2018-01-17T17:01:30-05:00
